Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17,804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding Key Factors Influencing Consumers' Willingness to Try, Buy, and Pay a Price Premium for Mycoproteins.
Dean D, Rombach M, Koning W, Vriesekoop F, Satyajaya W, Yuliandari P, Anderson M, Mongondry P, Urbano B, Luciano CAG, Hao W, Eastwick E, Achirimbi E, Jiang Z, Boereboom A, Rashid F, Khan I, Alvarez B, Aguiar LK. Dean D, et al. Among authors: jiang z. Nutrients. 2022 Aug 11;14(16):3292. doi: 10.3390/nu14163292. Nutrients. 2022. PMID: 36014797 Free PMC article.
Is cultured meat a promising consumer alternative? Exploring key factors determining consumer's willingness to try, buy and pay a premium for cultured meat.
Rombach M, Dean D, Vriesekoop F, de Koning W, Aguiar LK, Anderson M, Mongondry P, Oppong-Gyamfi M, Urbano B, Gómez Luciano CA, Hao W, Eastwick E, Jiang ZV, Boereboom A. Rombach M, et al. Appetite. 2022 Dec 1;179:106307. doi: 10.1016/j.appet.2022.106307. Epub 2022 Sep 9. Appetite. 2022. PMID: 36089124 Free article.
Expert consensus on the clinical application of immunotherapy in breast cancer: 2024.
Wang K, Yang J, Wang B, Liu Q, Wang X, Yin Y, Wang H, Wang S, Hao C, Hao X, Liu Y, Jiang Z; Chinese Society of Clinical Oncology Breast Cancer Committee*; Chinese Society of Clinical Oncology Breast Cancer Committee. Wang K, et al. Among authors: jiang z. Transl Breast Cancer Res. 2024 Apr 29;5:9. doi: 10.21037/tbcr-24-15. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 38751677 Free PMC article. Review.
Efficacy and safety of abemaciclib-based therapy versus tucidinostat-based therapy after progression on palbociclib in patients with HR+HER2- metastatic breast cancer.
Yuan Y, Zhang S, Wang T, Wang B, Wang S, Shi J, Sun T, Yin Y, Ouyang Q, Li J, Wen Y, Zhang L, Jiang Z. Yuan Y, et al. Among authors: jiang z. Transl Breast Cancer Res. 2023 Apr 30;4:10. doi: 10.21037/tbcr-23-9. eCollection 2023. Transl Breast Cancer Res. 2023. PMID: 38751483 Free PMC article.
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer: a long-term safety and overall survival update from the randomised, double-blind, placebo-controlled, phase 3 trial.
Zhang Q, Li W, Hu X, Sun T, Cui S, Wang S, Ouyang Q, Yin Y, Geng C, Tong Z, Cheng Y, Ning Z, Jiang Z. Zhang Q, et al. Among authors: jiang z. Transl Breast Cancer Res. 2023 Jul 30;4:18. doi: 10.21037/tbcr-23-31. eCollection 2023. Transl Breast Cancer Res. 2023. PMID: 38751475 Free PMC article.
17,804 results
You have reached the last available page of results. Please see the User Guide for more information.